-
1
-
-
79956067404
-
Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series
-
Alagille D., DaCosta H., Chen Y., Hemstapat K., Rodriguez A., Baldwin R.M., Conn P.J., Tamagnan G.D. Potent mGluR5 antagonists: pyridyl and thiazolyl-ethynyl-3,5-disubstituted-phenyl series. Bioorg. Med. Chem. Lett. 2011, 21:3243-3247.
-
(2011)
Bioorg. Med. Chem. Lett.
, vol.21
, pp. 3243-3247
-
-
Alagille, D.1
DaCosta, H.2
Chen, Y.3
Hemstapat, K.4
Rodriguez, A.5
Baldwin, R.M.6
Conn, P.J.7
Tamagnan, G.D.8
-
2
-
-
55049123814
-
Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction
-
Carroll F.I. Antagonists at metabotropic glutamate receptor subtype 5: structure activity relationships and therapeutic potential for addiction. Ann. N. Y. Acad. Sci. 2008, 1141:221-232.
-
(2008)
Ann. N. Y. Acad. Sci.
, vol.1141
, pp. 221-232
-
-
Carroll, F.I.1
-
3
-
-
0000789187
-
Suzuki-Miyaura coupling of alkynylboronic esters generated in situ from acetylenic derivatives
-
Castanet A.S., Colobert F., Schlama T. Suzuki-Miyaura coupling of alkynylboronic esters generated in situ from acetylenic derivatives. Org. Lett. 2000, 2:3559-3561.
-
(2000)
Org. Lett.
, vol.2
, pp. 3559-3561
-
-
Castanet, A.S.1
Colobert, F.2
Schlama, T.3
-
4
-
-
23044454240
-
Palladium-catalyzed Suzuki coupling with terminal alkynes-application to the synthesis of 2,3-disubstituted benzo[b]furans
-
Colobert F., Castanet A.S., Abillard O. Palladium-catalyzed Suzuki coupling with terminal alkynes-application to the synthesis of 2,3-disubstituted benzo[b]furans. Eur. J. Org. Chem. 2005, 3334-3341.
-
(2005)
Eur. J. Org. Chem.
, pp. 3334-3341
-
-
Colobert, F.1
Castanet, A.S.2
Abillard, O.3
-
5
-
-
20844455452
-
Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers
-
Hamill T.G., Krause S., Ryan C., Bonnefous C., Govek S., Seiders T.J., Cosford N.D.P., Roppe J., Kamenecka T., Patel S., Gibson R.E., Sanabria S., Riffel K., Eng W., King C., Yang X., Green M.D., O'Malley S.S., Hargreaves R., Burns H.D. Synthesis, characterization, and first successful monkey imaging studies of metabotropic glutamate receptor subtype 5 (mGluR5) PET radiotracers. Synapse 2005, 56:205-216.
-
(2005)
Synapse
, vol.56
, pp. 205-216
-
-
Hamill, T.G.1
Krause, S.2
Ryan, C.3
Bonnefous, C.4
Govek, S.5
Seiders, T.J.6
Cosford, N.D.P.7
Roppe, J.8
Kamenecka, T.9
Patel, S.10
Gibson, R.E.11
Sanabria, S.12
Riffel, K.13
Eng, W.14
King, C.15
Yang, X.16
Green, M.D.17
O'Malley, S.S.18
Hargreaves, R.19
Burns, H.D.20
more..
-
6
-
-
84879550537
-
18F-FPEB for imaging mGluR5 receptors in the human brain
-
18F-FPEB for imaging mGluR5 receptors in the human brain. J. Nucl. Med. 2011, 52:390.
-
(2011)
J. Nucl. Med.
, vol.52
, pp. 390
-
-
Kuwabara, H.1
Chamroonrat, W.2
Mathews, W.3
Waterhouse, R.4
Brasic, J.R.5
Guevara, M.R.6
Kumar, A.7
Hamill, T.8
Mozley, P.D.9
Wong, D.F.10
-
7
-
-
3142739322
-
Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia
-
Moghaddam B. Targeting metabotropic glutamate receptors for treatment of the cognitive symptoms of schizophrenia. Psychopharmacology 2004, 174:39-44.
-
(2004)
Psychopharmacology
, vol.174
, pp. 39-44
-
-
Moghaddam, B.1
-
8
-
-
84862865362
-
Metabotropic glutamate receptors: their therapeutic potential in anxiety
-
Spooren W., Lesage A., Lavreysen H., Gasparini F., Steckler T. Metabotropic glutamate receptors: their therapeutic potential in anxiety. Curr. Top. Behav. Neurosci. 2010, 2:391-413.
-
(2010)
Curr. Top. Behav. Neurosci.
, vol.2
, pp. 391-413
-
-
Spooren, W.1
Lesage, A.2
Lavreysen, H.3
Gasparini, F.4
Steckler, T.5
-
9
-
-
84876411974
-
18F]FPEB in bolus and bolus-plus-constant-infusion studies in humans
-
18F]FPEB in bolus and bolus-plus-constant-infusion studies in humans. J. Cereb. Blood Flow Metab. 2013, 33:532-541.
-
(2013)
J. Cereb. Blood Flow Metab.
, vol.33
, pp. 532-541
-
-
Sullivan, J.M.1
Lim, K.2
Labaree, D.3
Lin, S.F.4
McCarthy, T.J.5
Seibyl, J.P.6
Tamagnan, G.7
Huang, Y.8
Carson, R.E.9
Ding, Y.S.10
Morris, E.D.11
-
10
-
-
37249089038
-
18F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5
-
18F]fluoro-5-(2-pyridinylethynyl)benzonitrile as a PET radiotracer for imaging metabotropic glutamate receptor subtype 5. Synapse 2007, 61:951-961.
-
(2007)
Synapse
, vol.61
, pp. 951-961
-
-
Wang, J.Q.1
Tueckmantel, W.2
Zhu, A.3
Pellegrino, D.4
Brownell, A.L.5
-
11
-
-
34247572536
-
Metabotropic glutamate receptors in the control of mood disorders
-
Witkin J.M., Marek G.J., Johnson B.G., Schoepp D.D. Metabotropic glutamate receptors in the control of mood disorders. CNS Neurol. Disord. Drug Targets 2007, 6:87-100.
-
(2007)
CNS Neurol. Disord. Drug Targets
, vol.6
, pp. 87-100
-
-
Witkin, J.M.1
Marek, G.J.2
Johnson, B.G.3
Schoepp, D.D.4
-
12
-
-
84874881790
-
18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry
-
18F-FPEB, a PET radiopharmaceutical for quantifying metabotropic glutamate 5 receptors: a first-in-human study of radiochemical safety, biokinetics, and radiation dosimetry. J. Nucl. Med. 2013, 54:388-396.
-
(2013)
J. Nucl. Med.
, vol.54
, pp. 388-396
-
-
Wong, D.F.1
Waterhouse, R.2
Kuwabara, H.3
Kim, J.4
Brasic, J.R.5
Chamroonrat, W.6
Stabins, M.7
Holt, D.P.8
Dannals, R.F.9
Hamill, T.G.10
Mozley, P.D.11
|